Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
14.21
-0.12 (-0.84%)
Apr 1, 2025, 10:43 AM EDT - Market open
Avanos Medical Market Cap
Avanos Medical has a market cap or net worth of $653.70 million as of April 1, 2025. Its market cap has decreased by -27.59% in one year.
Market Cap
653.70M
Enterprise Value
721.73M
1-Year Change
-27.59%
Ranking
Category
Stock Price
$14.21
Market Cap Chart
Since October 21, 2014, Avanos Medical's market cap has decreased from $1.91B to $653.70M, a decrease of -65.74%. That is a compound annual growth rate of -9.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 641.70M | -12.29% |
| Dec 31, 2024 | 731.60M | -29.74% |
| Dec 29, 2023 | 1.04B | -17.24% |
| Dec 30, 2022 | 1.26B | -24.69% |
| Dec 31, 2021 | 1.67B | -23.88% |
| Dec 31, 2020 | 2.19B | 35.87% |
| Dec 31, 2019 | 1.62B | -23.97% |
| Dec 31, 2018 | 2.12B | -1.78% |
| Dec 29, 2017 | 2.16B | 25.31% |
| Dec 30, 2016 | 1.73B | 10.83% |
| Dec 31, 2015 | 1.56B | -26.40% |
| Dec 31, 2014 | 2.12B | 10.90% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |